Author

L. M. Poisson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:cell type annotation· 3 Approach:statistical model· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Assay:DNA methylation· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

H. Noushmehr· 3 shared T. M. Malta· 3 shared T. S. Sabedot· 3 shared A. C. deCarvalho· 2 shared A. V. Castro· 2 shared H. Kim· 2 shared J. Rock· 2 shared J. Snyder· 2 shared

Activity by Year

2017-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

H. Noushmehr

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment

F. S. Varn, K. C. Johnson, T. E. Wade, T. M. Malta, T. S. Sabedot, F. P. Barthel, H. Kim, N. Ahmed, I. Datta, J. S. Barnholtz-Sloan, S. Bakas, F. D'Angelo, H. K. Gan, L. Garofano, J. T. Huse, , The GLASS Consortium

This study analyzes longitudinal glioma data to identify recurrence-associated changes in genetics and microenvironment linked to therapy resistance.

bioRxiv · May 3, 2021Cancer Biology

DNA Methylation-based Signatures Classify Sporadic Pituitary Tumors According to Clinicopathological Features.

M. S. Mosella, T. S. Sabedot, T. C. Silva, T. M. Malta, F. D. Segato, K. P. Asmaro, M. Wells, A. Mukherjee, L. M. Poisson, J. Snyder, A. C. deCarvalho, T. Walbert, T. Aho, S. Kalkanis, P. C. Elias, , A. V. Castro

This paper identifies and validates DNA methylation signatures that classify sporadic pituitary tumors based on clinicopathological features and adenohypophyseal cell lineages.

Neuro-Oncology · Feb 25, 2021Peer-reviewedCancer Biology

Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers

H. Noushmehr, T. S. Sabedot, T. M. Malta, K. Nelson, J. Snyder, M. Wells, A. deCarvalho, A. Makherjee, D. Chitale, M. Mosella, K. Asmaro, A. M. Robin, M. L. Rosenblum, T. Mikkelsen, J. Rock, , A. V. Castro

This study identifies non-invasive circulating DNA methylation markers that can detect glioma and predict its prognosis from serum samples.

bioRxiv · Apr 8, 2019 · PreprintCancer Biology

Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma

A. C. deCarvalho, H. Kim, L. M. Poisson, M. E. Winn, C. Mueller, D. Cherba, J. Koeman, S. Seth, A. Protopopov, M. Felicella, S. Zheng, A. Multani, Y. Zhang, J. Zhang, D.-H. Nam, , R. Verhaak

This study shows that extrachromosomal DNA elements and chromosomal alterations in glioblastoma have distinct inheritance patterns and contribute to genomic heterogeneity during tumor evolution.

bioRxiv · Jun 27, 2017Cancer Biology